cancer clinical trials for FPBCC CTO Studies
97 FPBCC CTO Studies clinical trials found. View a list of all cancer clinical trial types.
-
A Phase III Randomized, Open-label Study of Rinatabart Sesutecan (Rina-S) Versus Treatment of Investigator's Choice (IC) in Patients With Platinum Resistant Ovarian Cancer
Current Status: Open
View links and contact information related to this clinical trial -
NRG-GY026: A Phase II/III Study of Paclitaxel/Carboplatin Alone or Combined with Either Trastuzumab and Hyaluronidase-Oysk (Herceptin Hylecta) or Pertuzumab, Trastuzumab, and Hyaluronidase-ZZXF (Phesgo) in HER2 Positive, Stage I-IV Endometrial Serous Carcinoma or Carcinosarcoma
Current Status: Open
View links and contact information related to this clinical trial -
A Non-Randomized Prospective Clinical Trial Comparint the Non-Inferiority of Salpingectomy to Salpingo-Oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers (SOROCk)
Current Status: Open
View links and contact information related to this clinical trial -
NRG-GY037: A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab Versus Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High Risk Locally Advanced Cervical Cancer
Current Status: Open
View links and contact information related to this clinical trial -
The Phase III 'High Five Trial' Five Fraction Radiation For High-Risk Prostate Cancer
Current Status: Open
View links and contact information related to this clinical trial -
A Randomized Phase II Trial of the Efficacy and Safety of Short and Long Course Radiation Therapy with and without BMX-001 as part of Total Neoadjuvant Therapy in Patients with Newly Diagnosed Locally Advanced Rectal Adenocarcinoma
Current Status: Open
View links and contact information related to this clinical trial -
A Phase I, Open-Label, Multicenter Study of INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Current Status: Not Open
View links and contact information related to this clinical trial -
A Phase II Study of Cabozantinib in Combination With Cemiplimab (Cabo-Cemiplimab) Versus Cabozantinib Alone in Adolescents and Adults With Advanced Adrenocortical Cancer
Current Status: Open
View links and contact information related to this clinical trial -
A Multicenter, Randomized, Double-blind, Placebo-Controlled Phase II Study to Investigate the Efficacy and Safety of CYP-001 in Combination with Corticosteroids vs Corticosteroids Alone for the Treatment of High-Risk Acute Graft Versus Host Disease
Current Status: Open
View links and contact information related to this clinical trial -
Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO
Current Status: Open
View links and contact information related to this clinical trial -
Safety and Tolerability of Ziftomenib Combinations for the Treatment of KMT2A-rearranged or NPM1-mutant Relapsed/Refractory Acute Myeloid Leukemia
Current Status: Open
View links and contact information related to this clinical trial -
Ivonescimab Combined with Chemotherapy Versus Pembrolizumab Combined with Chemotherapy for the First-line Treatment of Metastatic Squamous Non-small Cell Lung Cancer
Current Status: Open
View links and contact information related to this clinical trial -
A Phase I/II Multi-Center Study Evaluating the Safety and Efficacy of LYL314, a CD19/CD20 Dual-Targeting Chimeric Antigen Receptor T-Cell Therapy in Participants With Aggressive B-Cell Non-Hodgkin Lymphoma
Current Status: Open
View links and contact information related to this clinical trial -
Phase II trial to evaluate immune-related biomarkers for pathological response in stage II-III HER2-positive breast cancer receiving neoadjuvant chemotherapy with subsequent randomization to multi-epitope HER2 vaccine vs. placebo in patients with residual disease post-neoadjuvant chemotherapy
Current Status: Open
View links and contact information related to this clinical trial -
A Phase II, Open-Label, Multicenter Study of Inobrodib in Combination With Pomalidomide and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma (CCS1477-04)
Current Status: Open
View links and contact information related to this clinical trial -
A Pivotal Phase II/III, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Adaptive Design Study of L-Annamycin for Injection in Combination with Cytarabine Injection Versus Placebo in Combination with Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects with Refractory/Relapsed Acute Myeloid Leukemia
Current Status: Open
View links and contact information related to this clinical trial -
A Phase II study of Ipilimumab, Cabozantinib, and Nivolumab in rare genitourinary cancers (ICONIC)
Current Status: Open
View links and contact information related to this clinical trial -
A RANDOMIZED, PHASE III, OPEN-LABEL STUDY TO EVALUATE PF-08046054/SGN-PDL1V VERSUS DOCETAXEL IN ADULT PARTICIPANTS WITH PREVIOUSLY-TREATED PROGRAMMED CELL DEATH LIGAND 1 (PD-L1) POSITIVE NON-SMALL-CELL LUNG CANCER (NSCLC)
Current Status: Not Open
View links and contact information related to this clinical trial -
A Phase II Randomized Trial to Optimize GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation in Older Adults With Hematological Malignancies
Current Status: Open
View links and contact information related to this clinical trial -
Phase III Randomized Controlled Trial to Compare LYL314, a Dual Targeting CD19/CD20 CAR T-Cell Product Candidate, Versus Investigator's Choice of CD19 CAR T-Cell Therapy in Patients with Relapsed or Refractory Large B-Cell Lymphoma in the Second-Line Setting
Current Status: Open
View links and contact information related to this clinical trial -
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Current Status: Open
View links and contact information related to this clinical trial -
Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy
Current Status: Open
View links and contact information related to this clinical trial -
The Utility of Enhanced Recovery After Surgery (ERAS) Protocols in Breast Conserving Surgery: A Randomized Control Trial
Current Status: Open
View links and contact information related to this clinical trial -
Managed Access Program (MAP) Cohort Treatment Plan CCTL019B2003I to provide access for patients with out of specification leukapheresis product and/or out of specification manufactured tisagenlecleucel (CTL019; Kymriah®)
Current Status: Open
View links and contact information related to this clinical trial -
ROSETTA CRC-203: A Blinded, Randomized Phase II/III Study of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Current Status: Not Open
View links and contact information related to this clinical trial -
Phase III Randomized Trial of Standard Systemic Therapy (SST) versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
Current Status: Open
View links and contact information related to this clinical trial -
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder for Bladder Cancer Treatment, MODERN Study
Current Status: Open
View links and contact information related to this clinical trial -
Biomarker Approach to Screening for the early detection of HPV- related Oropharyngeal Cancer (BASH OPC)
Current Status: Open
View links and contact information related to this clinical trial -
High-dose rate brachytherapy boost with SBRT to prostate and pelvic nodes for the initial treatment of unfavorable intermediate or higher risk prostate cancer.
Current Status: Open
View links and contact information related to this clinical trial -
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma (EPCORE FL-2)
Current Status: Open
View links and contact information related to this clinical trial -
A First-In-Human Multicenter, Open-Label Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-319 in B-cell Malignancies
Current Status: Open
View links and contact information related to this clinical trial -
A randomized Phase II trial of adjuvant Pembrolizumab versus observation following curative resection for stage I non-small cell lung cancer (NSCLC) with primary tumors between 1-4 cm: Big Ten Cancer Research Consortium BTCRC-LUN18-153
Current Status: Open
View links and contact information related to this clinical trial -
Randomized Phase III Trial of mFOLFIRINOX +/- Nivolumab vs. FOLFOX +/- Nivolumab for First-Line Treatment of Metastatic HER2-Negative Gastroesophageal Adenocarcinoma
Current Status: Open
View links and contact information related to this clinical trial -
A Pilot study utilizing escitalopram to address cognitive dysfunction in Glioma patients
Current Status: Open
View links and contact information related to this clinical trial -
A Master Protocol to Evaluate the Long-Term Safety of Pirtobrutinib
Current Status: Open
View links and contact information related to this clinical trial -
Elacestrant Versus Standard Endocrine Therapy in Women and Men With Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast Cancer With High Risk of Recurrence-A Global, Multicenter, Randomized, Open-label Phase III Study
Current Status: Open
View links and contact information related to this clinical trial -
Randomized Phase II Study of Iberdomide Maintenance Therapy Following Idecaptagene Vicleucel CAR-T in Multiple Myeloma Patients
Current Status: Open
View links and contact information related to this clinical trial -
Resilience in Older Adults with Leukemia Receiving Initial Treatment: The ROAR-1 Study
Current Status: Open
View links and contact information related to this clinical trial -
Randomized Phase III Trial of Neoadjuvant Immunotherapy With Response-Adapted Treatment Versus Standard-of-Care Treatment for Resectable Stage III/IV Cutaneous Squamous Cell Carcinoma (C-PRE)
Current Status: Open
View links and contact information related to this clinical trial -
A Phase IIa Multicenter, Dose-Escalation and Dose Optimization Study of SYNC-T Therapy SV-102 for Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Current Status: Open
View links and contact information related to this clinical trial -
Expanded Access Protocol (EAP) For Subjects Receiving Idecabtagene Vicleucel That Is Nonconforming For Commercial Release
Current Status: Open
View links and contact information related to this clinical trial -
A Pragmatic Randomized Phase III Trial Evaluating Total Ablative Therapy for Patients with Limited Metastatic Colorectal Cancer: Evaluating Radiation, Ablation, and Surgery (ERASur)
Current Status: Open
View links and contact information related to this clinical trial -
A prospective, multicenter, open-label, randomized, actively controlled, parallel-group Phase III clinical trial to evaluate efficacy, safety, and tolerability of IMA203 versus investigator's choice in patients with previously treated, unresectable or metastatic cutaneous melanoma
Current Status: Open
View links and contact information related to this clinical trial -
Randomized, Open-label, Multicenter, Phase II Study Evaluating the Efficacy and Safety of Zilovertamab Vedotin (MK-2140) Plus R-CHP Versus Polatuzumab Vedotin Plus R-CHP in Treatment-naïve Participants With GCB Subtype of Diffuse Large B-cell Lymphoma (DLBCL)
Current Status: Open
View links and contact information related to this clinical trial -
Phase II Study of Dual Targeting of CD19 and CD20 Antigens Using Sequential CD19-directed CAR-T Cells Followed by Mosunetuzumab or Glofitamab in Relapsed or Refractory Diffuse Large B-cell or Transformed Follicular Lymphomas
Current Status: Open
View links and contact information related to this clinical trial -
Randomized Phase II/III Trial of 2nd Line Nivolumab + Paclitaxel + Ramucirumab Versus Paclitaxel + Ramucirumab in Patients with PD-L1 CPS >/= 1 Advanced Gastric and Esophageal Adenocarcinoma (PARAMUNE)
Current Status: Open
View links and contact information related to this clinical trial -
Consolidative Use of Radiotherapy to Block (CURB2) Oligoprogression In Patients With Metastatic Non-Small-Cell Lung Cancer
Current Status: Open
View links and contact information related to this clinical trial -
MYELOMATCH, Master Screening and Reassessment Protocol for Tier Advancement in the NCI myeloMATCH Clinical Trials
Current Status: Open
View links and contact information related to this clinical trial -
A Phase I Study of IM-1021 in Participants with Advanced Malignancies
Current Status: Open
View links and contact information related to this clinical trial -
OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy with Checkpoint Inhibitor Therapy
Current Status: Open
View links and contact information related to this clinical trial -
Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Current Status: Open
View links and contact information related to this clinical trial -
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
Current Status: Open
View links and contact information related to this clinical trial -
High-Dose Prophylactic Gabapentin (HOPE) to Prevent Opioid Use for Oral Mucositis Pain During Head and Neck Chemoradiotherapy: A Phase III Clinical Trial
Current Status: Open
View links and contact information related to this clinical trial -
An Open-label, Randomized Study of BMS-986489 (Atigotatug + Nivolumab Fixed-dose Combination) vs Durvalumab as Consolidation Therapy Following Chemoradiotherapy in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Current Status: Open
View links and contact information related to this clinical trial -
A Phase Ib, Open Label, Global, Multicenter, Dose Determination, Randomized Dose Expansion Study to Determine the Maximum Tolerated Dose, Assess the Safety and Tolerability, Pharmacokinetics and Preliminary Efficacy of Iberdomide (CC-220) in Combination With R-CHOP-21 and CC-99282 in Combination With R-CHOP-21 for Subjects With Previously Untreated Aggressive B-cell Lymphoma
Current Status: Open
View links and contact information related to this clinical trial -
A Measurable Residual Disease (MRD) Driven, Phase II Study of Venetoclax Plus Chemotherapy for Newly Diagnosed Younger Patients With Intermediate Risk Acute Myeloid Leukemia: A Tier 1 MYELOMATCH Clinical Trial
Current Status: Open
View links and contact information related to this clinical trial -
A Phase III Randomized, Open-label Study of MK-5684 Versus Alternative Abiraterone Acetate or Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) Previously Treated With Next-generation Hormonal Agent (NHA) and Taxane-based Chemotherapy
Current Status: Open
View links and contact information related to this clinical trial -
Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Current Status: Open
View links and contact information related to this clinical trial -
A Phase III, Double-blind, Randomized Study of Zolbetuximab in Combination With Pembrolizumab and Chemotherapy (CAPOX or mFOLFOX6) in First-line Treatment of Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma in Participants Whose Tumors Are HER2-negative, Claudin (CLDN) 18.2-positive and Programmed Death-ligand 1 (PD-L1)-Positive
Current Status: Open
View links and contact information related to this clinical trial -
A Phase II Study of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed or Refractory CD10-Negative Diffuse-Large B-Cell Lymphoma (DLBCL) and High-Grade B-Cell Lymphoma with MYC and BCL2 rearrangements (HGBCL-DH-BCL2)
Current Status: Open
View links and contact information related to this clinical trial -
Halt Aging in Survivors of Blood Cancers: the HALTAging-1 Study
Current Status: Open
View links and contact information related to this clinical trial -
A Phase I/II Study of Inhaled KB707 in Patients with Advanced Solid Tumor Malignancies Affecting the Lungs
Current Status: Open
View links and contact information related to this clinical trial -
A Randomized Phase III Study of Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Patients with High Risk RetroPeritoneal Sarcoma (STRASS 2)
Current Status: Open
View links and contact information related to this clinical trial -
A Phase II, Open-Label, Randomized, Multicenter Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease
Current Status: Open
View links and contact information related to this clinical trial -
A Phase III, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 Versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012)
Current Status: Open
View links and contact information related to this clinical trial -
A Randomized, Double-Blind, Active-Control, Multicenter Phase III Trial of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
Current Status: Open
View links and contact information related to this clinical trial -
A Phase II Randomized Study of Safety and Efficacy of a Multiple Antigen Vaccine (STEMVAC) in Non-Small-Cell Lung Cancer Patients
Current Status: Open
View links and contact information related to this clinical trial -
A Phase III, Multicenter, Randomized, Open-label Study of Ifinatamab Deruxtecan (I-DXd), a B7-H3 Antibody Drug Conjugate (ADC), Versus Treatment of Physician's Choice (TPC) in Subjects With Relapsed Small Cell Lung Cancer (SCLC) (IDeate-Lung02)
Current Status: Open
View links and contact information related to this clinical trial -
A Phase III Study of Cabazitaxel with or without Carboplatin in Patients with Metastatic Castrate-resistant Prostate Cancer (MCrPC), Stratified by Aggressive Variant Signature (CARAVAN)
Current Status: Open
View links and contact information related to this clinical trial -
Evaluation of Gut Microbiome Diversity in Breast Cancer Survivors Following Active Cancer Therapy
Current Status: Open
View links and contact information related to this clinical trial -
A Randomized, Multicenter, Placebo-controlled, Phase III Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects With Residual Disease or High-Risk PCR After Both Neoadjuvant and Postoperative Adjuvant Trastuzumab-based Therapy (FLAMINGO-01)
Current Status: Open
View links and contact information related to this clinical trial -
A Phase I, multicenter, open-label study of UB-VV111 in combination with Rapamycin in relapsed or refractory (R/R) CD19+ B-Cell malignancies
Current Status: Open
View links and contact information related to this clinical trial -
An Open-Label, Dose Escalation and Dose Expansion Trial Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of Orally Administered CA-4948 in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma
Current Status: Open
View links and contact information related to this clinical trial -
Cognition in older adults with myeloma undergoing CAR-T therapy
Current Status: Open
View links and contact information related to this clinical trial -
Establishment of a national biorepository to advance studies of immune-related adverse events
Current Status: Open
View links and contact information related to this clinical trial -
A Phase III Randomized Study Comparing Teclistamab in Combination With Daratumumab SC and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab SC and Lenalidomide (Tal-DR) Versus Daratumumab SC, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma Who Are Either Ineligible or Not Intended for Autologous Stem Cell Transplant as Initial Therapy
Current Status: Open
View links and contact information related to this clinical trial -
PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Patients with Recurrent Prostate Cancer After Prostatectomy
Current Status: Open
View links and contact information related to this clinical trial -
Evaluation of Trabedersen (OT-101) with Pembrolizumab in Patients with Newly Diagnosed Advanced Non-Small Cell Lung Cancer and positive PD-L1
Current Status: Open
View links and contact information related to this clinical trial -
A Randomized Phase III Trial of Continuous vs. Intermittent Maintenance Therapy with Zanubrutinib as Upfront Treatment in Older Patients with Mantle Cell Lymphoma (INTERCON)
Current Status: Open
View links and contact information related to this clinical trial -
Randomized Phase II Trial of Anti-Lag-3 and Anti-PD-1 Blockade vs. SOC in Patients With Recurrent Glioblastoma
Current Status: Open
View links and contact information related to this clinical trial -
Treatment practices and outcomes of adults with therapy-related acute myeloid leukemia (AML) and AML with myelodysplasia related changes
Current Status: Open (affiliates Only)
View links and contact information related to this clinical trial -
A Phase II/III, Multicenter, Randomized Open-Label Study of Zanzalintinib vs Everolimus in Participants With Previously Treated, Unresectable, Locally Advanced or Metastatic Neuroendocrine Tumors
Current Status: Open
View links and contact information related to this clinical trial -
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Current Status: Open
View links and contact information related to this clinical trial -
Abiraterone/Prednisone + Standard ADT vs Standard ADT for Prostate Cancer Patients with PSMA-Positive Conventionally Negative Pelvic Lymphadenopathy
Current Status: Open
View links and contact information related to this clinical trial -
A Randomized Study Evaluating GLIADEL Compared to Stereotactic Radiosurgery in Patients with Metastatic Brain Disease
Current Status: Open
View links and contact information related to this clinical trial -
A Phase II Study of Combined Amivantamab, Carboplatin and Paclitaxel in Unresectable Locally Recurrent or Metastatic Head and Neck Cancer
Current Status: Not Open
View links and contact information related to this clinical trial -
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia and Non-Hodgkin's Lymphoma
Current Status: Open
View links and contact information related to this clinical trial -
A Phase I Study of Metronomic Temozolomide with PCI-24781 for Patients with Recurrent High Grade Glioma
Current Status: Open
View links and contact information related to this clinical trial -
A Pilot, Randomized, Double-blind, Placebo-controlled Study using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular Therapy in Multiple Myeloma and Lymphoma: The PRIMAL Trial
Current Status: Open
View links and contact information related to this clinical trial -
A Phase I Multicenter, Open-Label Study to Determine the Recommended Dose and Evaluate the Safety and Preliminary Efficacy of BMS-986393 in Novel Combinations in Participants with Relapsed and/or Refractory Multiple Myeloma and Determine the Recommended Dose For Each Add On Investigational Component
Current Status: Open
View links and contact information related to this clinical trial -
Shorter Anthracycline-Free Chemo Immunotherapy Adapted to Pathological Response in Early Triple Negative Breast Cancer (SCARLET), A Randomized Phase III Study
Current Status: Open
View links and contact information related to this clinical trial -
A Randomized Phase II Study Comparing Sequential High dose Testosterone and Enzalutamide to Enzalutamide alone in Asymptomatic Men with Castration Resistant Metastatic Prostate Cancer
Current Status: Open
View links and contact information related to this clinical trial -
A Randomized Phase III Study of Datopotomab-Deruxtecan (Dato-DXd) plus Carboplatin or Cisplatin versus Gemcitabine plus Carboplatin or Cisplatin in Subjects with Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC) who progressed during or after Enfortumab Vedotin (EV) plus Pembrolizumab Combination Treatment. TROPIONUrothelial03 (TU03).
Current Status: Not Open
View links and contact information related to this clinical trial -
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 (OFSET)
Current Status: Open
View links and contact information related to this clinical trial -
A Phase I, Dose Escalation and Dose Expansion, Safety and Tolerability Study of onCARlytics (CF33-CD19), Administered Intravenously or Intratumorally in Combination with Blinatumomab in Adults with Advanced or Metastatic Solid Tumors
Current Status: Not Open
View links and contact information related to this clinical trial -
ShortStop-HER2: Shortened Duration of Adjuvant Therapy in Patients With Early-Stage HER2+ Breast Cancer Who Achieve pCR After Neoadjuvant Chemotherapy With HER2 Blockade
Current Status: Open
View links and contact information related to this clinical trial -
A Phase III, Randomized Study of Daratumumab, Cyclophosphamide, Bortezomib and Dexamethasone (Dara-VCD) Induction Followed by Autologous Stem Cell Transplant or Dara-VCD Consolidation and Daratumumab Maintenance in Patients with Newly Diagnosed AL Amyloidosis
Current Status: Open
View links and contact information related to this clinical trial